Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes
Clinical trial NCT04373967 · UNKNOWN
Trial details
- NCT number
- NCT04373967
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-29
- Primary completion
- 2021-12-01
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.